Life Insurance
Consensus Index

AI Consensus Fit Review

OneAmerica Whole Life Insurance Fit Review for Dividends

OneAmerica is a good fit for a buyer who wants participating whole life insurance with guaranteed cash-value features plus an optional, company-specific mechanism for linking part of the dividend to S&P 500 performance.

Research: 2026-09-207 usable platform responsesRead the methodology ↗

Share

Answer Capsule

OneAmerica is a good fit for a buyer who wants participating whole life insurance with guaranteed cash-value features plus an optional, company-specific mechanism for linking part of the dividend to S&P 500 performance. Four of seven platforms named OneAmerica during ranking discovery, at an average listed rank of 7.75 and a best rank of 7. The strongest reason to consider it is the Indexed Dividend Crediting Option (IDO) Rider, which OneAmerica describes as allowing policyholders to allocate all or part of a dividend to an S&P 500-linked calculation with potential for up to double the dividend in a given year [1]. The main limitation is that OneAmerica does not publish a headline dividend interest rate, and no current premium quote or complete contract illustration was publicly available for the buyer profile.

Research Snapshot

FieldFinding
Platform mentions in ranking stage4 of 7 platforms (anthropic, google, kimi, perplexity)
Share of included platform responses57.1%
Average listed rank7.75
Best listed rank7
Relevant product/model/planAmerican United Life participating whole life, including Legacy and Legacy 121 policies with the Indexed Dividend Crediting Option (IDO) Rider when available
Overall use-case fitGood, with an important evidence gap
Research date2026-09-20

Why OneAmerica Qualified for This Study

Questions This Section Answers

  • Is OneAmerica a good choice for Whole Life Insurance for Dividends?
  • How many AI platforms named OneAmerica for participating whole life insurance with dividends?

OneAmerica qualified because it issues participating whole life insurance through American United Life Insurance Company and because four of the seven included platforms named it during ranking discovery. It was not a unanimous pick: three platforms did not name it in the ranking stage, and its average listed rank of 7.75 places it behind the largest mutual carriers in this study's discovery results.

The company's qualification rests on three supplied facts. First, OneAmerica states that its whole life products are issued and underwritten by American United Life Insurance Company, and the public product page identifies Whole Life 95, Whole Life 121, and Whole Life Select [2]. Second, AM Best's 2025 rating review lists the OneAmerica Group, including American United Life, at A+ Superior with a stable outlook and a very strong balance-sheet-strength assessment [3]. Third, OneAmerica publicly describes the IDO Rider for Legacy and Legacy 121 policyholders, which the company says can link all or part of a dividend to an S&P 500 calculation with potential for up to double the dividend in a given year [4].

Platform fit ratings were not uniform. Five platforms rated OneAmerica a good fit (openai, anthropic, google, grok, perplexity), one rated it mixed (deepseek), and one rated it uncertain (kimi). That spread is itself a finding: the case for OneAmerica depends heavily on how much weight a buyer places on the IDO Rider versus publicly disclosed dividend scales.

The Product, Model, Plan, or Service Most Relevant to Whole Life Insurance for Dividends

Questions This Section Answers

  • Which OneAmerica whole life product should a dividend-focused buyer ask about first?
  • Is the OneAmerica Indexed Dividend Crediting Option Rider available on every OneAmerica whole life policy?

The most relevant offering is American United Life participating whole life, specifically the Legacy and Legacy 121 policies with the Indexed Dividend Crediting Option (IDO) Rider when available. This is the product family the supplied platform responses most consistently tie to the dividend use case.

OneAmerica's public whole-life page identifies Whole Life 95, Whole Life 121, and Whole Life Select, and states that the products are issued and underwritten by American United Life Insurance Company [5]. The company also states that its whole life policies provide level premiums, a level death benefit subject to loans and withdrawals, and guaranteed cash-value growth independent of market performance [5].

The IDO Rider is the differentiator. OneAmerica's announcement describes the rider for Legacy and Legacy 121, including S&P 500 linkage, partial allocation, potential up to double dividend, downside protection, and state and form limitations [7]. The company states that an IDO-linked dividend cannot be negative and that whole life guarantees remain in place if the market underperforms [7]. Independent coverage describes the IDO Rider as what makes OneAmerica genuinely unique in the whole life space [9].

There is a naming conflict buyers should know about. The supplied recommendation names Legacy and Legacy 121, while the current public whole-life page emphasizes Whole Life 95, Whole Life 121, and Whole Life Select. The relationship between these names and current state-specific offerings is unclear from the reviewed materials. One platform also reported that all three products can be enhanced with the IDO Rider and a Paid-Up Additions Rider at a 6% upfront load [10], while another reported the IDO Rider is available on Legacy and Legacy 121 only. Treat the exact rider-to-product mapping as unconfirmed until the carrier or agent confirms it in writing.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about OneAmerica for dividend-paying whole life insurance?
  • Does OneAmerica have strong financial strength ratings for a participating whole life policy?

The platforms agreed on four points: OneAmerica issues participating whole life through American United Life; the IDO Rider is a genuine product differentiator; the company has a recent pattern of dividend increases; and financial-strength ratings support consideration.

On product structure, the platforms consistently identified American United Life as the issuing entity and Legacy/Legacy 121 with the IDO Rider as the relevant design [11]. OneAmerica states that its whole life products are issued and underwritten by American United Life Insurance Company [11].

On the IDO Rider, the agreement was strong. OneAmerica says policyholders may allocate all or part of a dividend to an S&P 500-linked calculation, with potential for up to double the dividend in a given year, while the remaining dividend, if any, receives the scheduled treatment [15]. The company also states that an IDO-linked dividend cannot be negative and that whole life guarantees remain in place if the market underperforms [15].

On dividend trend, OneAmerica announced a 10-basis-point increase in its dividend interest rate for 2026, representing 17% growth over the 2025 dividend payment [17]. The 2025 payout exceeded $36.4 million, up 13% from 2024 [19]. OneAmerica also states it has maintained a mutual organization structure for nearly 150 years [21].

On financial strength, AM Best's 2025 review lists the OneAmerica Group, including American United Life, at A+ Superior with a stable outlook [22]. OneAmerica's own ratings page states that its companies receive an A+ (Superior) rating from AM Best [23]. Financial-strength ratings concern claims-paying ability, not the size or future level of policy dividends.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Why do AI platforms disagree about whether OneAmerica is the best carrier for whole life dividends?
  • Is OneAmerica's dividend interest rate publicly disclosed for comparison with MassMutual or New York Life?

The platforms disagreed most sharply on dividend transparency, early cash-value competitiveness, and current ratings. These are the areas a buyer should treat as unresolved.

On dividend disclosure, the disagreement is material. One independent analysis states that OneAmerica is not included in dividend-rate comparison analyses because it does not publish dividend interest rate information in accessible form [24]. One platform reported that OneAmerica does not publicly disclose a single headline dividend interest rate but shows consistent double-digit growth in payouts [26]. Another platform reported that the exact 2026 dividend interest rate percentage is not disclosed in general consumer-facing press releases, though a 10-basis-point scale increase was publicized [27]. A third-party 2026 comparison reports a 10-basis-point OneAmerica dividend change, but those figures were not independently verified against a current official dividend announcement [28].

On cash-value competitiveness, the platforms split. One independent review states that Penn Mutual typically produces higher straight cash value growth due to superior policy design and that, for pure cash value maximization, Penn Mutual wins [29]. Another independent source describes OneAmerica as a flexibility-and-service carrier rather than a performance-first one, with below-average illustrated growth [31], and notes that its long-term cash growth often runs in the bottom quartile of mutual carriers [32]. One platform reported that OneAmerica's total dividend payout is materially smaller than MassMutual's or New York Life's, while its double-digit growth trajectory shows commitment [33].

On ratings, the platforms reported different dates and outcomes. One platform reported AUL and State Life rated A+ by A.M. Best on August 29, 2024, and AA- by S&P on August 22, 2024 [34]. Another reported that S&P Global Ratings lowered its long-term financial strength ratings on OneAmerica's core operating entities, including American United Life, to A+ from AA- on September 18, 2026 [35]. A third reported that S&P's outlook changed to negative while AM Best remained stable [36]. OneAmerica's official rating page displays A+ and AA- ratings dated 2023, while AM Best's 2025 review reports A+ Superior and aa- issuer credit ratings for the OneAmerica Group. These are not necessarily inconsistent, but the dates and rating scope should be checked directly before purchase.

One platform, kimi, rated OneAmerica uncertain and reported that its dividend history, current dividend interest rate, and competitive standing could not be verified from available sources. That platform also noted that OneAmerica does not appear in independent comparative analyses of dividend-paying whole life carriers found in its sources [37]. This is a platform-reported limitation, not a proven absence.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features make OneAmerica competitive for a participating whole life policy focused on dividends?
  • How does OneAmerica's non-direct recognition treatment affect policy loans and dividends?

OneAmerica's use-case-specific strengths are the IDO Rider, guaranteed whole life features, non-direct recognition treatment, and a reported low paid-up-additions load. Each carries a verification requirement.

The IDO Rider allows policyholders to allocate all or part of a dividend to an S&P 500-linked calculation, with potential for up to double the dividend in a given year and a floor that prevents a negative dividend [38]. The public announcement is from 2017, so current availability, mechanics, limits, and form terms require confirmation.

Guaranteed features are standard whole life: level premiums, a level death benefit subject to loans and withdrawals, and guaranteed cash-value growth independent of market performance [41]. OneAmerica states that its whole life options include growth through dividends with flexibility through various riders [43].

Non-direct recognition is a reported advantage for policy-loan strategies. Independent coverage states that OneAmerica is a non-direct recognition company that credits full dividends on the entire cash value, including the portion borrowed against [44]. One platform reported that non-direct recognition companies like OneAmerica credit full dividends on entire cash value [47]. This treatment must be confirmed in the specific policy form and state.

Paid-up additions economics were reported favorably by one platform: a 6% upfront load on the Paid-Up Additions Rider, described as among the lowest PUA charges in the industry [48]. This is a platform-reported figure from independent review coverage, not a company-published fee schedule.

OneAmerica also offers a Loan Interest Rate Limitation Rider at no additional cost on Whole Life Select, which one platform reported prevents unintended lapse when outstanding loans reach 95% of policy cash value [50]. That is a company-owned claim about a specific product.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does OneAmerica whole life insurance cost per month, and are there setup or cancellation fees?
  • What fees and loads apply to the OneAmerica IDO Rider and paid-up additions?

No consumer-specific premium, minimum premium, dividend scale, or guaranteed/illustrated cash-value schedule was publicly verifiable from the reviewed sources. Whole life pricing depends on age, underwriting, risk class, face amount, payment period, riders, state, and policy design. Pricing confidence across the supplied platform responses was low.

Known costs are limited. Premiums are policy-specific and were not publicly quoted. The cost of the IDO Rider, if any, was not stated in the reviewed public materials; verify whether it has a separate charge or affects dividend treatment. Policy loans accrue interest under the contract, and the applicable rate was not verified. Loans, withdrawals, riders, and paid-up additions can change cash value, death benefit, lapse risk, and tax results [51].

One platform reported that the IDO Rider carries no additional premium on qualifying policies and that the Paid-Up Additions Rider carries a 6% upfront load [52]. Another platform reported that the IDO Rider is available on Legacy and Legacy 121 only, which conflicts with the broader availability claim. Treat both as platform-reported until confirmed.

Contract terms are state-specific. OneAmerica states that whole life products and forms may not be available in all states or may vary by state [51]. One independent source reports that OneAmerica sells in 49 states and Washington, D.C., but not in New York [55]. Surrender values, surrender charges, nonforfeiture options, and cancellation consequences must be obtained from the state-specific illustration and contract. No fixed-term subscription or publicly stated cancellation fee was identified; this is insurance, so stopping premiums can have policy-specific consequences.

Best Suited For

Questions This Section Answers

  • Who is OneAmerica best suited for when buying participating whole life insurance for dividends?
  • Is OneAmerica a good fit for a buyer who wants index-linked dividend upside without losing whole life guarantees?

OneAmerica is best suited for buyers who value participating whole life guarantees plus optional indexed dividend upside, and who are willing to obtain a personalized illustration rather than rely on headline dividend claims.

The strongest fit is a buyer who specifically wants the IDO Rider's structure: allocate all or part of a dividend to an S&P 500-linked calculation, with potential for up to double the dividend in a strong market year and a floor that prevents a negative dividend [56]. One platform described the IDO Rider as what makes OneAmerica genuinely unique in the whole life space [57].

A second fit is a buyer comparing financially strong carriers. AM Best's 2025 review lists the OneAmerica Group, including American United Life, at A+ Superior with a stable outlook and a very strong balance-sheet-strength assessment [58]. OneAmerica states it has maintained a mutual organization structure for nearly 150 years [59].

A third fit is a buyer who may value non-direct recognition loan treatment, subject to confirmation in the specific policy form and state. Independent coverage states that OneAmerica credits full dividends on the entire cash value, including borrowed portions [60].

A fourth fit is a buyer who wants a recent dividend-increase trend. OneAmerica announced a 10-basis-point increase in its dividend interest rate for 2026, representing 17% growth over the 2025 dividend payment [62].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose OneAmerica for Whole Life Insurance for Dividends?
  • Is OneAmerica a poor fit for a buyer who needs a published dividend interest rate before applying?

OneAmerica is probably not the best fit for buyers whose primary objective is the highest independently verified dividend scale, the largest published dividend payout, or the strongest publicly documented historical dividend record.

A buyer who needs a fully verified, long-published dividend history and current dividend scale before applying should look elsewhere first. One independent analysis states that OneAmerica is not included in dividend-rate comparison analyses because it does not publish dividend interest rate information in accessible form [64]. One platform reported that OneAmerica does not publicly disclose a single headline dividend interest rate [66].

A buyer prioritizing maximum cash-value accumulation based on independently comparable current illustrations may find OneAmerica trails. One independent review states that Penn Mutual typically produces higher straight cash value growth due to superior policy design [67]. Another source describes OneAmerica as a flexibility-and-service carrier rather than a performance-first one, with below-average illustrated growth [68].

A buyer who needs a product confirmed as available in a particular state without agent or state-specific policy-form verification should not assume availability. OneAmerica states that whole life products and forms may not be available in all states or may vary by state [69]. One independent source reports no availability in New York [70].

A buyer who wants direct recognition policy design should note that OneAmerica is reported as non-direct recognition only [71].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to OneAmerica for a buyer who needs a published dividend interest rate?
  • When should a buyer choose MassMutual, Penn Mutual, or New York Life over OneAmerica for whole life dividends?

Another option may be better when the buyer's decision criterion is dividend-rate transparency, early cash-value growth, or the largest published payout pool.

If the buyer prioritizes a larger publicly documented dividend history or wants multiple current illustrations for cash-value comparison, the supplied responses point to MassMutual, New York Life, Guardian, Penn Mutual, and Lafayette Life as established participating carriers to compare [72]. One platform reported that MassMutual published the highest dividend rate at 6.60% for 2026 [73]. Another reported that Northwestern Mutual publishes a 5.75% dividend interest rate for 2026 and has paid dividends since 1872, while New York Life has paid dividends since 1854 [74]. These are platform-reported figures from carrier and third-party sources, not independently verified here.

If the buyer wants a clearer current dividend-scale publication, a carrier with a published scale may be preferable to OneAmerica's non-disclosed approach [76].

If the buyer prioritizes certainty of premiums and benefits over dividend potential, a non-participating guaranteed whole life product would not satisfy the same participating-dividend objective [72].

If the buyer is in New York, OneAmerica is reported as unavailable there [78].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with OneAmerica before signing a whole life insurance contract?
  • Which OneAmerica policy form and dividend scale details must be verified in writing?

The following questions come from the supplied platform responses and should be answered in writing before purchase.

Is Legacy or Legacy 121 currently available in the buyer's state, and what is the exact policy form number? Is the policy participating, and what is the insurer's current dividend scale, dividend interest assumption, and total dividend payout history for comparable policies? What portion of the illustrated cash value and death benefit is guaranteed versus non-guaranteed?

How exactly is the IDO dividend calculated, including index measurement, participation factor, maximum, allocation limits, election timing, and treatment in negative or flat index years? Does the IDO Rider have a separate charge, reduce the standard dividend, or affect paid-up additions and premium-offset assumptions? What is the current S&P 500 cap or floor for the IDO Rider, and has it changed year over year?

What is the policy's loan recognition method, loan interest rate, preferred-loan eligibility, and treatment of dividends on borrowed cash value? What are the paid-up-additions loads, surrender charges, rider charges, administrative charges, and premium requirements? What happens if premiums are reduced, skipped, or stopped, and how would that affect lapse risk and tax treatment?

Are the quoted AM Best and any S&P ratings current for American United Life specifically, rather than only for a parent or rating unit? Can the agent provide side-by-side guaranteed and current-assumption illustrations against at least two established participating carriers?

Final AI Consensus Verdict

OneAmerica is a good fit, with an important evidence gap. It offers a credible participating-whole-life platform through American United Life, strong publicly documented financial-strength ratings, and the distinctive IDO Rider for potential indexed dividend enhancement. It should be shortlisted for buyers who value that feature, but it should not be selected solely on the possibility of doubled dividends.

The buyer should require a current state-specific contract, illustration, dividend-scale disclosure, loan terms, and comparable competing illustrations before purchasing. The platform fit ratings were five good, one mixed, and one uncertain, and the disagreement centered on dividend transparency and cash-value competitiveness rather than on whether OneAmerica is a legitimate participating carrier.

How This Review Was Produced

This review used the supplied platform responses for the Whole Life Insurance for Dividends use case, the entity ranking statistics for OneAmerica, and the supplied citation catalog. The study research date is 2026-09-20. Platform-reported research dates differ: deepseek reported 2026-01-15, while the other six platforms reported 2026-09-21. Those platform dates are provenance metadata and do not independently prove freshness.

Platform mentions in the ranking stage count only platforms that named OneAmerica during ranking discovery. All seven included platforms evaluated fit, but only four named the entity in the ranking stage. Company-owned citations materially outnumber independent citations in the supplied catalog, so company claims are not described here as independently verified.

Methodology Limitations

Several limitations apply. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. One platform, deepseek, reported that search was not enabled, so its claims require explicit verification before being described as current facts.

Conflicting product names, pricing, and capabilities were not resolved by guessing. The Legacy and Legacy 121 naming versus Whole Life 95, Whole Life 121, and Whole Life Select remains unresolved. The IDO Rider's current availability, mechanics, limits, and form terms require confirmation, and the public announcement is from 2017. No current premium quote or complete contract illustration was publicly available for the buyer profile.

Ratings dates and scope conflict across sources, including a reported S&P downgrade to A+ in September 2026 and a reported negative S&P outlook, against AM Best's stable A+ position. The deterministic identity audit notes that official-site retrieval failed for one or more mentions and that a product-labeled company mention was merged using matching company-name and supplied-domain signatures. No failed fetch was used as a verified domain key.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Additional AI research evidence78 records
    1. AI research evidence record openai:c2
    2. AI research evidence record openai:c1
    3. AI research evidence record openai:c5
    4. AI research evidence record openai:c2
    5. AI research evidence record openai:c1
    6. AI research evidence record openai:c4
    7. AI research evidence record openai:c2
    8. AI research evidence record anthropic:src9-4
    9. AI research evidence record anthropic:src39-11
    10. AI research evidence record anthropic:src8-13
    11. AI research evidence record openai:c1
    12. AI research evidence record anthropic:src1-11
    13. AI research evidence record deepseek:c1
    14. AI research evidence record perplexity:c5
    15. AI research evidence record openai:c2
    16. AI research evidence record anthropic:src9-4
    17. AI research evidence record anthropic:src29-4
    18. AI research evidence record google:1.1.1
    19. AI research evidence record anthropic:src28-4
    20. AI research evidence record anthropic:src30-9
    21. AI research evidence record anthropic:src28-3
    22. AI research evidence record openai:c5
    23. AI research evidence record google:1.4.1
    24. AI research evidence record anthropic:src4-1
    25. AI research evidence record google:2.2.6
    26. AI research evidence record anthropic:src12-5
    27. AI research evidence record google:1.1.1
    28. AI research evidence record openai:c6
    29. AI research evidence record anthropic:src12-12
    30. AI research evidence record anthropic:src12-14
    31. AI research evidence record anthropic:src33-3
    32. AI research evidence record google:3.1.7
    33. AI research evidence record anthropic:src24-2
    34. AI research evidence record anthropic:src28-1
    35. AI research evidence record google:2.1.1
    36. AI research evidence record grok:0
    37. AI research evidence record kimi:ig-dividend-history
    38. AI research evidence record openai:c2
    39. AI research evidence record anthropic:src9-1
    40. AI research evidence record anthropic:src9-4
    41. AI research evidence record openai:c1
    42. AI research evidence record openai:c4
    43. AI research evidence record anthropic:src6-3
    44. AI research evidence record anthropic:src7-1
    45. AI research evidence record anthropic:src12-8
    46. AI research evidence record anthropic:src12-9
    47. AI research evidence record anthropic:src42-5
    48. AI research evidence record anthropic:src8-13
    49. AI research evidence record anthropic:src39-10
    50. AI research evidence record google:1.2.2
    51. AI research evidence record openai:c1
    52. AI research evidence record anthropic:src8-13
    53. AI research evidence record anthropic:src39-10
    54. AI research evidence record openai:c2
    55. AI research evidence record anthropic:src33-5
    56. AI research evidence record openai:c2
    57. AI research evidence record anthropic:src39-11
    58. AI research evidence record openai:c5
    59. AI research evidence record anthropic:src28-3
    60. AI research evidence record anthropic:src12-8
    61. AI research evidence record anthropic:src12-9
    62. AI research evidence record anthropic:src29-4
    63. AI research evidence record google:1.1.1
    64. AI research evidence record anthropic:src4-1
    65. AI research evidence record google:2.2.6
    66. AI research evidence record anthropic:src12-5
    67. AI research evidence record anthropic:src12-12
    68. AI research evidence record anthropic:src33-3
    69. AI research evidence record openai:c1
    70. AI research evidence record anthropic:src33-5
    71. AI research evidence record anthropic:src12-8
    72. AI research evidence record openai:c6
    73. AI research evidence record anthropic:src12-3
    74. AI research evidence record kimi:nm-dividends
    75. AI research evidence record kimi:nyl-dividends
    76. AI research evidence record anthropic:src4-1
    77. AI research evidence record google:2.2.6
    78. AI research evidence record anthropic:src33-5

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 20, 2026
Platforms analyzed
7
Source records
39
Ranking mentions
4 of 7
Platform share
57%
Final consensus rank
#6

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

18 independent · 20 company-owned · 1 unclear

Evidence support

30 direct · 8 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

ee32e2998f5dc0902c1b71c1c77a09d2c06d59a7bd695ee541fddba82634d4c0